Search NASA⌕ Search

Engineering topics

Phillips, David H

Publications and source records attributed to Phillips, David H.

Combining visible shadowgraph imaging with x-ray imaging for dynamic shock experiments

Interrogating ejecta particles launched from target materials that are undergoing dynamic shock can be done with both x-ray imaging and visible shadowgraph imaging. Our dynamic testing must be done inside a containment vessel with limited access ports available. We designed an imaging system to relay both types of imaging systems through a single port using the same optical relay and then splitting the images onto three separate high-speed imaging cameras outside the containment vessel. X-ray imaging provides ejecta density measurements. Shadowgraph imaging that is done at two wavelengths (blue and red) constrains ejecta particle size distributions and provides areal density measurements of the ejecta cloud. The ejecta particles are positioned 225 mm before the x-ray scintillators; this arrangement permits a folded mirror system to allow the shadowgraph data to bypass the x-ray scintillators. This configuration results in spatial separations between the intermediate image planes of the x-ray and shadowgraph images along the optical axis. At the position of the x-ray intermediate image plane, mirrors are positioned such that the shadowgraph images are kicked out and their images are sent on to different cameras. Positioning of the large doublet relay lenses keeps shrapnel from impacting the vessel containment windows.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗

LOW SCATTER, HIGH KILOVOLT, A-SI FLAT PANEL X-RAY DETECTOR

We have been using amorphous silicon (a-Si) flat panel detectors in high energy (>400 kV) cone beam computed tomography (CT) applications for a number of years. We have found that these detectors have a significant amount of internal scatter that degrades the accuracy of attenuation images. The scatter errors cause cupping and streaking artifacts that are practically indistinguishable from beam hardening artifacts. Residual artifacts remain after beam hardening correction and over correction increases noise in CT reconstructions. Another important limitation of existing detectors is that they have a high failure rate, especially when operating at megavolt x-ray energies even with a well collimated beam. Due to the limitations of the current detectors, we decided to design a detector specifically for high energies that has significantly reduced scatter. In collaboration with IMTEC, we have built a prototype amorphous silicon flat panel detector that has both improved imaging response and increased lifetime. LANL's contribution is the ''transparent panel concept''(patent pending), in which structures in the x-ray beam path are either eliminated or made as transparent to x-rays as practical (low atomic number and low areal density). This reduces scatter, makes attenuation measurements more accurate, improves the ability to make corrections for beam hardening, and increases signal to noise ratio in DR images and CT reconstructions. IMTEC's contribution is an improved shielding design that will increase the lifetime of the panel. Preliminary results showing the dramatic reduction in self scatter from the panel will be presented as well as the effect of this improvement on CT images.

36 MATERIALS SCIENCE↗

Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53

Aristolochic acid (AA) is the causative agent of urothelial tumours associated with aristolochic acid nephropathy. These tumours contain TP53 mutations and over-express TP53. We compared transcriptional and translational responses of two isogenic HCT116 cell lines, one expressing TP53 (p53-WT) and the other with this gene knocked out (p53-null), to treatment with aristolochic acid I (AAI) (50-100 {mu}M) for 6-48 h. Modulation of 118 genes was observed in p53-WT cells and 123 genes in p53-null cells. Some genes, including INSIG1, EGR1, CAV1, LCN2 and CCNG1, were differentially expressed in the two cell lines. CDKN1A was selectively up-regulated in p53-WT cells, leading to accumulation of TP53 and CDKN1A. Apoptotic signalling, measured by caspase-3 and -7 activity, was TP53-dependent. Both cell types accumulated in S phase, suggesting that AAI-DNA adducts interfere with DNA replication, independently of TP53 status. The oncogene MYC, frequently over-expressed in urothelial tumours, was up-regulated by AAI, whereas FOS was down-regulated. Observed modulation of genes involved in endocytosis, e.g. RAB5A, may be relevant to the known inhibition of receptor-mediated endocytosis, an early sign of AA-mediated proximal tubule injury. AAI-DNA adduct formation was significantly greater in p53-WT cells than in p53-null cells. Collectively, phenotypic anchoring of the AAI-induced expression profiles to DNA adduct formation, cell-cycle parameters, TP53 expression and apoptosis identified several genes linked to these biological outcomes, some of which are TP53-dependent. These results strengthen the importance of TP53 in AA-induced cancer, and indicate that other alterations, e.g. to MYC oncogenic pathways, may also contribute.

60 APPLIED LIFE SCIENCES↗